pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·3h ago·1 min read
save

Webinar Explores How US Biotechs Can Compete and Collaborate with China’s Growing Industry

Oct 15, 2026·read at BioSpace ↗Neutral

BioSpace is hosting a webinar titled "The China question: Can US biotechs lead as investment heads east?" on October 15, 2026. The event will feature a panel of experts who will discuss how China is shaping the future of biotech and what that means for companies on both sides of the Pacific.

The conversation will address contrasting perspectives that view China as a well of innovation or as a competitive challenge to U.S. dominance. It will explore why large pharmaceutical firms are eager to access Chinese therapies while U.S. biotech firms are searching for a clear role in the evolving landscape.

Among the speakers is Lila Hope, a partner at Sidley, who advises biotech, pharmaceutical and related companies on licensing, collaboration and other commercial agreements. Participants can register to watch the session online.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Webinar: The China question: Can US biotechs lead as investment heads east?”

read at BioSpace ↗
949 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ovid Therapeutics Inc.3BRISTOL2BRISTOL-MYERS2Bristol-Myers Squibb Co2LEADING2Strand Therapeutics Inc2TEVA PHARMACEUTICAL INDUSTRIES LTD2Moderna, Inc.NOVARTISUltragenyx Pharmaceutical Inc.
drugs
Immuno-oncologyRare Diseaseinfluenza vaccine
topics
Vaccine2Big PharmaDiagnostics CompanyOncologyRare DiseasemRNA Therapeutic

related stories

  • 3h agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: OMass obtains $310M; Soufflé cooks up $135MFierce Biotech
  • Sep 2Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN dealsBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 6d agoHow Abogen went from COVID hype to a $7.8B Novartis dealBioSpace